• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白三烯拮抗剂对实验性迟发性脑血管痉挛的影响。

Effect of leukotriene antagonist on experimental delayed cerebral vasospasm.

作者信息

Kobayashi H, Ide H, Handa Y, Aradachi H, Arai Y, Kubota T

机构信息

Department of Neurosurgery, Fukui Medical School, Japan.

出版信息

Neurosurgery. 1992 Sep;31(3):550-5; discussion 555-6. doi: 10.1227/00006123-199209000-00018.

DOI:10.1227/00006123-199209000-00018
PMID:1407436
Abstract

Experimental delayed cerebral vasospasm was produced in 16 adult mongrel dogs by the "two-hemorrhage" method of intracisternal injections of autologous arterial blood. Group 1 was a control group. Group 2 was a treatment group that received an intravenous injection of ONO-1078, a novel potent leukotriene antagonist, once a day for 7 days just after the first cisternal injection of the blood. Angiography was performed on Days 0 and 7, and the cerebrospinal fluid levels of leukotriene C4 (LTC4) were measured on Days 0, 3, and 7. The cisternal levels of LTC4 increased after subarachnoid hemorrhage in both groups. But the cerebrospinal fluid levels of LTC4 in the treatment group were significantly lower than those in the control group (P less than 0.05). The angiographic vasospasm after subarachnoid hemorrhage was partially prevented with the treatment of intravenous injections of ONO-1078 (P less than 0.001). These results suggest that LTC4 may play a role in the pathogenesis of delayed cerebral vasospasm, directly or indirectly, and ONO-1078 may have a therapeutic effect on the prevention of the development of delayed cerebral vasospasm.

摘要

通过脑池内注射自体动脉血的“两次出血”方法,在16只成年杂种犬中诱发实验性迟发性脑血管痉挛。第1组为对照组。第2组为治疗组,在首次脑池内注射血液后,每天静脉注射一次新型强效白三烯拮抗剂ONO-1078,共7天。在第0天和第7天进行血管造影,并在第0天、第3天和第7天测量脑脊液中白三烯C4(LTC4)的水平。两组蛛网膜下腔出血后,脑池内LTC4水平均升高。但治疗组脑脊液中LTC4水平明显低于对照组(P<0.05)。静脉注射ONO-1078治疗可部分预防蛛网膜下腔出血后的血管造影血管痉挛(P<0.001)。这些结果表明,LTC4可能直接或间接在迟发性脑血管痉挛的发病机制中起作用,且ONO-1078可能对预防迟发性脑血管痉挛的发生具有治疗作用。

相似文献

1
Effect of leukotriene antagonist on experimental delayed cerebral vasospasm.白三烯拮抗剂对实验性迟发性脑血管痉挛的影响。
Neurosurgery. 1992 Sep;31(3):550-5; discussion 555-6. doi: 10.1227/00006123-199209000-00018.
2
CSF leukotriene C4 following subarachnoid hemorrhage.蛛网膜下腔出血后的脑脊液白三烯C4
J Neurosurg. 1988 Oct;69(4):488-93. doi: 10.3171/jns.1988.69.4.0488.
3
U74389G prevents vasospasm after subarachnoid hemorrhage in dogs.
Neurosurgery. 1998 Jun;42(6):1339-45; discussion 1345-6. doi: 10.1097/00006123-199806000-00089.
4
Gene transfer to cerebral blood vessels after subarachnoid hemorrhage.
Stroke. 1997 Apr;28(4):822-8; discussion 828-9. doi: 10.1161/01.str.28.4.822.
5
Delayed CSF lavage for arteriographic and morphological vasospasm after experimental SAH.
J Neurosurg. 1985 Dec;63(6):949-58. doi: 10.3171/jns.1985.63.6.0949.
6
Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage.单次脑池内大剂量注射重组组织型纤溶酶原激活剂预防实验性蛛网膜下腔出血后迟发性脑血管痉挛的疗效
Neurosurgery. 1989 Oct;25(4):590-8. doi: 10.1097/00006123-198910000-00013.
7
Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor.使用鞘内注射一氧化氮供体逆转脑血管痉挛。
J Neurosurg. 1998 Aug;89(2):279-88. doi: 10.3171/jns.1998.89.2.0279.
8
Immunohistochemistry of leukotriene C4 in experimental cerebral vasospasm.实验性脑血管痉挛中白三烯C4的免疫组织化学
Acta Neuropathol. 1991;81(4):401-7. doi: 10.1007/BF00293461.
9
Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist.新型口服活性内皮素受体拮抗剂RO 47 - 0203预防实验性蛛网膜下腔出血后脑血管痉挛
Neurosurgery. 1996 Jan;38(1):115-20. doi: 10.1097/00006123-199601000-00028.
10
[A model for intracranial vasospasm in subarachnoid hemorrhage].[蛛网膜下腔出血颅内血管痉挛模型]
Neurochirurgie. 1991;37(1):44-9.

引用本文的文献

1
Inflammatory Pathways Following Subarachnoid Hemorrhage.蛛网膜下腔出血后的炎症通路。
Cell Mol Neurobiol. 2020 Jul;40(5):675-693. doi: 10.1007/s10571-019-00767-4. Epub 2019 Dec 5.
2
Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: Experimental-Clinical Disconnect and the Unmet Need.颅内出血后迟发性脑缺血:实验-临床脱节和未满足的需求。
Neurocrit Care. 2020 Feb;32(1):238-251. doi: 10.1007/s12028-018-0650-5.
3
Montelukast, a cysteinyl leukotriene receptor-1 antagonist protects against hippocampal injury induced by transient global cerebral ischemia and reperfusion in rats.
孟鲁司特,一种半胱氨酰白三烯受体-1拮抗剂,可保护大鼠免受短暂性全脑缺血再灌注诱导的海马损伤。
Neurochem Res. 2015 Jan;40(1):139-50. doi: 10.1007/s11064-014-1478-9. Epub 2014 Nov 18.
4
Development of calcitonin gene-related peptide slow-release tablet implanted in CSF space for prevention of cerebral vasospasm after experimental subarachnoid haemorrhage.植入脑脊液间隙的降钙素基因相关肽缓释片用于预防实验性蛛网膜下腔出血后脑血管痉挛的研究进展
Acta Neurochir (Wien). 1996;138(10):1230-40. doi: 10.1007/BF01809753.